Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-25
2007-12-25
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S099000
Reexamination Certificate
active
10531648
ABSTRACT:
A compound selected from those of formula (I):wherein:W1, with the carbon atoms to which it is bonded, represents phenyl or pyridyl,Z represents a group selected from hydrogen, halogen, linear or branched (C1-C6)alkyl, aryl, aryl-(C1-C6)alkyl, aryloxy, aryl-(C1-C6)alkoxy, hydroxy and linear or branched (C1-C6)alkoxy,R1is as defined in the description,R2represents hydrogen or —CH2CH2O—R8,R3and R4each represents hydrogen, linear or branched (C1-C6)alkyl, aryl or aryl-(C1-C6)alkyl,n represents an integer of from 1 to 6 inclusive,its isomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.
REFERENCES:
patent: 0841337 (1998-05-01), None
Motohashi,Pharmaceutical Society of Japan, 1983, 103, 364-371.
Morgan, et al.,Photochemistry and Photobiology, 2000, 71, 747-757.
International Search Report for International ApplicationNo. PCT/FR2003/03068, Feb. 23, 2004.
International Preliminary Examination Report for International ApplicationNo. PCT/FR2003/03068, Feb. 23, 2004.
Caignard Daniel-Henri
Coudert Gerard
Hickman John
Kraus-Berthier Laurence
Lepifre Franck
Hueschen and Sage
Les Laboratories Servier
LandOfFree
Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3865843